Literature DB >> 19373564

What tissue bankers should know about the use of allograft tendons and cartilage in orthopaedics.

Alan Getgood1, Steve Bollen.   

Abstract

Tendon and osteochondral allograft are key requirements for reconstructive orthopaedic surgery. Their successful use has been published repeatedly, however, they are associated with potential significant problems, which both patients and surgeons should be aware of. This review highlights the advantages and disadvantages associated with the clinical use of both tendon and osteochondral allograft. Particular emphasis is paid to graft immunogenicity, viability, incorporation and disease transmission, with specific examples from the literature illustrating each point.

Entities:  

Mesh:

Year:  2009        PMID: 19373564     DOI: 10.1007/s10561-009-9129-0

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  3 in total

1.  Novel treatment of a failed quadriceps tendon repair in a diabetic patient using a patella-quadriceps tendon allograft.

Authors:  Sasha C Druskin; Scott A Rodeo
Journal:  HSS J       Date:  2012-09-28

2.  Evaluation of Polycaprolactone-Associated Human Nasal Chondrocytes as a Therapeutic Agent for Cartilage Repair.

Authors:  Do Hyun Kim; Mi Hyun Lim; Se Hwan Hwang; Sung Won Kim; Jung Ho Jeun; Sun Hwa Park; WeonSun Lee; Sang Hi Park; Mi Yeon Kwon
Journal:  Tissue Eng Regen Med       Date:  2019-08-19       Impact factor: 4.169

3.  Viral Inactivation of Human Osteochondral Grafts with Methylene Blue and Light.

Authors:  Donna M Squillace; Zhixing Zhao; Gazell M Call; Jizong Gao; Jian Q Yao
Journal:  Cartilage       Date:  2014-01       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.